• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AMGEN / INSULET CORPORATION NEULASTA ONPRO; INJECTOR, PEN

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AMGEN / INSULET CORPORATION NEULASTA ONPRO; INJECTOR, PEN Back to Search Results
Health Effect - Clinical Code Insufficient Information (4580)
Date of Event 03/31/2023
Type of Reportable Event Malfunction
Event or Problem Description
Neulasta device malfunctioned with red light and alarming while patient was leaving the facility.He was able to come back into the center for a second placement without any complication.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NEULASTA ONPRO
Common Device Name
INJECTOR, PEN
Manufacturer (Section D)
AMGEN / INSULET CORPORATION
MDR Report Key16700941
Report NumberMW5116428
Device Sequence Number11960587
Product Code NSC
Combination Product (Y/N)N
Initial Reporter StateCO
Initial Reporter CountryUS
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Voluntary
Initial Reporter Occupation Risk Manager
Type of Report Initial
Report Date (Section B) 04/03/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Is the Reporter a Health Professional? Yes
Initial Date Received by Manufacturer Not provided
Initial Report FDA Received Date04/06/2023
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Patient Age73 YR
Patient SexMale
-
-